Skip to content
★ Sign in to follow
MN

Menelas N. Pangalos

Executive
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
8
Companies
2
▲ Purchases (2 ops.)
€390k
▼ Sales (0 ops.)
—

Latest filing published 11 Jun 2026 for BIOGEN INC..

Filing timeline

BuySale
Menelas N. Pangalos

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
100%
Median T+90
+86.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Mar 2026 · 250 days ago · €174k
    +138.7%
    Entry US$2.66 · Close at T+90 US$6.35
  • Filed 24 Sept 2025 · 410 days ago · €216k
    +267.5%
    Entry US$2.65 · Close at T+365 US$9.74

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Menelas N. Pangalos: trading record in brief

Menelas N. Pangalos is a declared insider at 2 companies; the most frequent names are Absci Corp and Biogen Inc. Between 12 June 2024 and 9 June 2026, the trades on record add up to 8 filings.

Every open-market trade on record is a purchase: 2 purchases worth €390k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants and 1 option exercise. In 2026 alone, the filings show 1 purchase and no sales.

On 11 June 2026 came the latest disclosure, a share grant in Biogen Inc. The last purchase on record was published on 3 March 2026, which is 250 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Menelas N. Pangalos

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations